Sunitinib malate
产品编号: DC3146
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Sunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.
Cas No.: |
341031-54-7 |
名称: |
(Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide ,(S)-2-hydroxysuccinic acid |
别名: |
SU-11248,SU11248 |
SMILES: |
O=C(NCCN(CC)CC)C1=C(NC(/C=C2C(NC3=C2C=C(C=C3)F)=O)=C1C)C.O=C([C@H](CC(O)=O)O)O |
分子式: |
C22H27FN4O2.C4H6O5 |
分子量: |
532.56 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
Description of Sunitinib malate: Sunitinib malate, also known as SU11248, is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of va |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
TITLE |
DOWNLOAD |
MSDS_3368_DC3146_341031-54-7 |
|
COA
LOT NO. |
DOWNLOAD |
|
|
询盘